Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

Email Alert Subscription

You may automatically receive OPKO Health, Inc. financial information by email. Please enter your preferences for email notifications below and click "Submit".

Unsubscribe from Investor Relations email alerts.

Our email alerts provide automated opt-out methods as well as complete contact information.